All Access Articles |
- EyePoint Doses First Patients in Phase 3 Trials for Duravyu™ | 2026-03-02 | UNITED STATES
- EyePoint Initiates Phase 3 Trial for Duravyu™ | 2025-10-15 | BIOTECHNOLOGY
- EyePoint Pharmaceuticals Enrolls 800 Patients for Wet AMD Treatment | 2025-07-29 | BIOTECHNOLOGY
- EyePoint Pharmaceuticals Boasts Strong Safety Profile and $370M Cash Position | 2025-03-04 | BIOTECHNOLOGY